CORDIS launches Finnish Presidency R&D and Innovation Information Service

CORDIS, the Community Research and Development Information Service, has launched a new online service covering the research and innovation activities carried out under the Finnish Presidency of the Council of the European Union (1 July to 31 December 2006). Highlighting the latest news and most relevant developments in the research and development (R&D) policy sphere during this period, the Finnish Presidency Service is part of the gateway to national and regional activities on CORDIS.

Particular emphasis is placed on the Finnish research and innovation programme during the country's time at the helm. During its six-month Presidency, Finland's main aim will be to successfully conclude the negotiations on the Seventh R&D Framework Programme (2007 - 2013). Furthermore, agreement to start work on the International Thermonuclear Experimental Reactor (ITER) project will be sought.

In more general terms, Finland intends to work towards improving the EU's global competitiveness and R&D capacities. Particular emphasis is also put on Europe's innovative capacities and on developing markets to create more demand for innovation.

Throughout the Presidency, there will be numerous events, ranging from formal and informal ministerial meetings to open conferences, to support Finnish efforts to develop and strengthen the European innovation environment. Many events will also support and improve cooperation in innovation and research policy and between researchers and financing organisations.

The CORDIS Finnish Presidency Service is a central gateway to R&D and innovation activities carried out during the Finnish Presidency. It provides up-to-date information on policy initiatives, and highlights the latest R&D developments in a dedicated news section. Visitors to the site can also stay informed about upcoming and recent events organised by Finland.

Links to other relevant websites, notably those of the Finnish R&D and innovation actors, provide readers with important resources for further information about the R&D and innovation sector in one of the world's most innovative countries. Analyses of the innovation and R&D systems in Finland, as well as a comprehensive projects and results database, are also made available via the national CORDIS service for Finland.

Finally, the 'showcases' will provide an in-depth overview of particularly important initiatives, success stories or developments.

The Finnish Presidency service on CORDIS is therefore a comprehensive gateway for everyone interested in R&D policy in Europe and in Finland over the next six months. It was developed by CORDIS in cooperation with the relevant Finnish authorities and is available in English and Finnish.

For further information please visit:
http://cordis.europa.eu/finland/presidency/home_en.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...